Greg Brown

Greg Brown has a diversified work experience in the biopharmaceutical industry. Greg is currently serving on the Advisory Board of FemHealth Ventures since January 2022. Prior to this, they held the position of Chief Executive Officer at Memgen starting from February 2020. From 2016, Greg has been the Chairman of the Board at Lisata Therapeutics, Inc. Greg is also a Founder and Member of the Senior Advisor Board at HealthCare Royalty Partners, a private investment firm. In addition, Greg has served as a Director at Aquestive Therapeutics and Faron Pharmaceuticals, Oy. Greg was also a Director at FAST BioMedical from February 2020 to December 2022. Earlier in their career, Greg worked as a Partner at Paul Capital Partners and Managing Director at Adams, Harkness & Hill. Greg began their career as a Vice President at Vector Securities International Inc. in 1992.

Greg Brown's education history begins in 1971 when they attended Yale University. Greg completed their undergraduate degree, graduating with an A.B. in an unspecified field of study in 1975. After that, from 1975 to 1979, they attended the State University of New York Upstate Medical University, where they earned their MD degree. Finally, in 1990, Greg Brown enrolled at Harvard Business School and pursued their Master of Business Administration (MBA) degree, which they completed in 1992.